3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Kidney Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Interventions
Bevacizumab
12
olaparib
10
Paclitaxel
10
Carboplatin
10
liposomal doxorubicin
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
mirvetuximab soravtansine
4
Topotecan
4
Taxes
4
Immunoglobulin G
4
Gemcitabine
4
Disulfides
4
Biopsy
4
pembrolizumab
3
cediranib
3
Oxaliplatin
2
Doxorubicin
2
1-dodecylpyridoxal
2
tremelimumab
1
trastuzumab deruxtecan
1
sotorasib
1
sarilumab
1
palbociclib
1
niraparib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
ipatasertib
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.